Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether giving extra arginine to patients with
sickle cell disease seeking treatment for vaso-occlusive painful events (VOE) will decrease
pain scores, decrease need for pain medications or decrease length of hospital stay or
emergency department visit.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Emory University
Collaborators:
Children's Healthcare of Atlanta National Center for Complementary and Integrative Health (NCCIH)